Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 8.92M | $ 0 | $ 0 | $ 0 | 0% |
3/31/2025 | $ 21.66M | $ 0 | $ 0 | $ 0 | 0% |
12/31/2024 | $ 35.44M | $ 0 | $ 0 | $ 0 | 0% |
9/30/2024 | $ 46.54M | $ 82.67M | $ 0 | $ 0 | -177.62% |
6/30/2024 | $ 25.52M | $ 82.67M | $ 0 | $ 0 | -323.97% |
3/31/2024 | $ 38.5M | $ 82.67M | $ 0 | $ 0 | -214.72% |
12/31/2023 | $ 31.3M | $ 82.82M | $ 0 | $ 0 | -264.61% |
9/30/2023 | $ 48.57M | $ 153K | $ 0 | $ 0 | -0.31% |
6/30/2023 | $ 19.71M | $ 127K | $ 0 | $ 0 | -0.64% |
3/31/2023 | $ 19.95M | $ 66K | $ 0 | $ 0 | -0.33% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for VYNE THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 53.7M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 297.15M ]
(=) Shareholder Yield [ -18.07% ]
Minimum
Jun 30, 2024
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |